Ann: Investor Presentation, page-70

A confession... I have bought in at 54c - the top of the surge (Yep poor timing as it's turned out), so I'm sitting at a pretty loss at the moment. However, I do feel my reasoning for buying here is unchanged. Income in 2017 set to grow as each EU country comes on board. Trial concluding in the US mid 2017 set to double the target of 140k sales in 2018, and other indications to pursue (epilepsy, depression and tinnitus) that have the potential to make this a billion dollar company. At the very least we have a large market for ASD and willing customers, not confined to the 3-12yr old market NTI are targeting to begin with. It's much much bigger than that as teens and adults alike will benefit from this medical device.

Good luck to the fortunate buyers coming in at this level and below. I've another parcel to add in the next week or so, and then sit back and let the company roll out through Italy, Germany, the UK and France.